More than 850 investors express interest
More than 850 investors have expressed their interest in backing Australian-based medicinal cannabis company, Medibis, as it shares its commitment to distribute and eventually produce one of the most effective, patient-centric, and sustainably grown medicinal cannabis treatments globally.
Chapel and Calvert co-founded Medibis three years ago, turning their careers in mining, engineering and business executive leadership into medicinal cannabis after discovering the compelling science and research globally.
Medibis is also forging a research partnership with The University of Queensland, School of Veterinary Science, headed by Professor of Veterinary Pharmacology, Prof Paul Mills BVSc PhD MACVSc GCEd MPhil (Vet Ed) PFHEA.
Medibis plans to be a world-leading cultivator, manufacturer, researcher, and exporter of medicinal cannabis and related products to the Australian and global markets, and will be based at the FKG Group Toowoomba Precinct (AATLIS).
read the full article here: https://thegreenfund.com/australians-rush-to-back-new-medical-cannabis-company-medibis